Key facts
- This page summarizes Loic Antoine Henriet's Form 4 filing for Pasqal Holding SA (PSQL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Aug 2026, 16:42.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Received pursuant to the consummation of the Issuer's business combination, in connection with the Agreement and Plan of Merger, dated as of February 28, 2026 (as amended, supplemented or otherwise modified from time to time, the "Business Combination Agreement"), by and among Bleichroeder Acquisition Corp. II ("Bleichroeder"), Bleichroeder Acquisition France Merger Sub 2 ("Merger Sub"), and Pasqal Holding SAS ("Legacy Pasqal"), which provided for, among other things and subject to the terms and conditions contained in the Business Combination Agreement,
Footnote F2
(Continued from foontnote 1) (i) the merger of Bleichroeder with and into Merger Sub, with Merger Sub continuing as the surviving company (the "Reincorporation Merger", and Merger Sub as the surviving company of the Reincorporation Merger, the "Bleichroeder Surviving Corporation") and (ii) the merger of Legacy Pasqal with and into the Bleichroeder Surviving Corporation, with the Bleichroeder Surviving Corporation continuing as the surviving company and changing its name to "Pasqal Holding SA" (the "Merger").
Footnote F3
Represents ordinary shares of Legacy Pasqal that were held directly by the Reporting Person, which, upon the consummation of the Issuer's business combination and pursuant to the exchange ratio of 22.7361449900136 set forth in the Business Combination Agreement (the "Exchange Ratio"), were automatically converted into newly issued ordinary shares of the Issuer.
Footnote F4
The exerecise price is Eur 50.
Footnote F5
As of the date hereof, 129,055 of the BSPCEs have fully vested and are exercisable for 2,934,213 ordinary shares of the Issuer. The remaining BSPCEs will vest in equal monthly installments of (i) 1,946 BSPCEs from September 1, 2026 to July 1, 2028, (ii) 1,442 BSPCEs from September 1, 2026 to January 1, 2029, and (iii) 3,544 BSPCEs from September 1, 2026 to July 1, 2029.
Footnote F6
Pursuant to the Merger, legacy BSPCEs of Legacy Pasqal were assumed by the Issuer, granting each holder the right to subscribe for ordinary shares of the Issuer, with the number of underlying shares adjusted, as applicable, to reflect the Exchange Ratio.